B
Barry Diner
Researcher at Emory University
Publications - 11
Citations - 333
Barry Diner is an academic researcher from Emory University. The author has contributed to research in topics: Asthma & Randomized controlled trial. The author has an hindex of 7, co-authored 11 publications receiving 327 citations. Previous affiliations of Barry Diner include Brooklyn Hospital Center.
Papers
More filters
Journal ArticleDOI
Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials
TL;DR: Calcitonin appears to be effective in the management of acute pain associated with acute osteoporotic vertebral compression fractures by shortening time to mobilization.
Journal ArticleDOI
Aerosolized Magnesium Sulfate for Acute Asthma* A Systematic Review
Maurice Blitz,Sandra Blitz,Rodney Hughes,Barry Diner,Richard Beasley,Jennifer A. Knopp,Brian H. Rowe +6 more
TL;DR: The use of nebulized MgSO(4), particularly in addition to a beta(2)-agonist, in the treatment of an acute asthma exacerbation appears to produce benefits with respect to improved pulmonary function and may reduce the number of hospital admissions.
Journal ArticleDOI
Graduate medical education and knowledge translation: role models, information pipelines, and practice change thresholds.
Barry Diner,Chris Carpenter,Tara O'Connell,Peter Pang,Michael D. Brown,Rawle A. Seupaul,James J. Celentano,Dan Mayer +7 more
TL;DR: The possibility that basic familiarity, along with the pipeline by Pathman et al., may improve KT uptake may be an initial starting point for research on GME and KT, and aims to create astarting point for future work and discussions in the realm of KT and GM.
Journal ArticleDOI
Inaccuracy of "personal best" peak expiratory flow rate reported by inner-city patients with acute asthma.
TL;DR: If a predicted PEF of at least 70% was used as the criterion for ED discharge, as several asthma guidelines recommend, then using patients' reported personal best PEF would have led to inappropriate ED discharge for some patients.
Journal ArticleDOI
Adding long-acting β-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma : A randomized controlled trial
Brian H. Rowe,Eric Wong,Sandra Blitz,Barry Diner,Duncan Mackey,Scott Ross,Ambikaipakan Senthilselvan +6 more
TL;DR: Outpatient treatment with a short course of systemic corticosteroids combined with ICSs is adequate for most patients with asthma discharged from the emergency department; those already receiving ICS agents may benefit from ICS/LABA combination therapy to improve quality of life.